Background illustration for clinical trials search

Paid Clinical Trials Huntsville

Discover 94 paid clinical trials in Huntsville, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

for
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Location: Huntsville AL, Birmingham AL, Mandeville LA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 12+

Code: NCT06338995

Phase 3, Recruiting
Active & Responsive

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

for
Irritable Bowel Syndrome
Location: Huntsville AL, Birmingham AL, Chattanooga TN,
Sponsor: Dynogen Pharmaceuticals

Sex: Female

Age: 18 - 65

Code: NCT00547469

Phase 2, Phase 3, Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Huntsville AL, Chattanooga TN, Birmingham AL,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

for
Hyperphosphatemia,
Location: Huntsville AL, Dalton GA, Toledo OH, Kansas City MO,
Sponsor: R1 Therapeutics

Sex: All

Age: 18+

Code: NCT06712654

Phase 2, Recruiting
Active & Responsive

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

for
Percutaneous Coronary Intervention,
Location: Huntsville AL, Birmingham AL, Nashville TN, Tupelo MS,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06909565

Phase 4, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

for
Treatment Resistant Depression
Location: Huntsville AL, Birmingham AL, Brentwood TN, Marietta GA,
Sponsor: LivaNova

Sex: All

Age: 18+

Code: NCT03887715

Recruiting
Active & Responsive

MicroRNA Correlates of Childhood Maltreatment and Suicidality

for
Major Depressive Disorder, Suicidal Ideation
Location: Huntsville AL, Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 60

Code: NCT04923685

Recruiting
Active & Responsive

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

for
Heart Failure With Preserved Ejection Fraction,
Location: Huntsville AL, Tullahoma TN, Birmingham AL, Atlanta GA,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07037459

Phase 3, Recruiting
Active & Responsive

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Huntsville AL, Nashville TN, Atlanta GA, Germantown TN,
Sponsor: Immuneering Corporation

Sex: All

Age: 18+

Code: NCT07562152

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Location: Huntsville AL, Nashville TN, Atlanta GA, St Louis MO,
Sponsor: C4 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07284758

Phase 2, Recruiting
Active & Responsive

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

for
Prostate Cancer,
Location: Huntsville AL, Nashville TN, Cincinnati OH,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT07005154

Phase 2, Recruiting
Active & Responsive

Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

for
Arthritis, Rheumatoid
Location: Huntsville AL, Tupelo MS, Bowling Green KY,
Sponsor: Crescendo Bioscience

Sex: All

Age: 18 - 70+

Code: NCT02832297

Recruiting
Active & Responsive

Evaluating Stairway Designs for Individuals With Vision Impairment

for
Vision, Low, Mobility Limitation
Location: Huntsville AL
Sponsor: The University of Alabama in Huntsville

Sex: All

Age: 65+

Code: NCT07337317

Recruiting
Active & Responsive

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Guntersville AL, Anniston AL, Marietta GA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase 3, Recruiting

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

for
Proteinuric Kidney Disease
Location: Huntsville AL, Decatur AL, Chattanooga TN, Tupelo MS,
Sponsor: Maze Therapeutics

Sex: All

Age: 18 - 68

Code: NCT06830629

Phase 2, Recruiting

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

for
Clostridoides Difficile Associated Disease
Location: Huntsville AL, Athens AL, Guntersville AL, Nashville TN,
Sponsor: Pfizer

Sex: All

Age: 65+

Code: NCT07282665

Phase 3, Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for
Untreated Follicular Lymphoma
Location: Huntsville AL, Nashville TN, Macon GA, Charlotte NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase 3, Recruiting

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

for
Focal Seizure, Epilepsy, Focal Epilepsy
Location: Huntsville AL, Nashville TN, Bentonville AR, Raleigh NC,
Sponsor: Rapport Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT07594119

Phase 3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Huntsville AL, Chattanooga TN, Birmingham AL, Tupelo MS,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for
Heart Failure
Location: Huntsville AL, Sheffield AL, Birmingham AL,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase 3, Recruiting